XML 81 R65.htm IDEA: XBRL DOCUMENT v3.26.1
FINANCIAL RISK MANAGEMENT (Tables)
12 Months Ended
Dec. 31, 2025
Financial Risk Management [Abstract]  
Schedule of Disclosure of capital structure
The capital structure of the partnership consists of corporate borrowings and non-recourse borrowings in subsidiaries of the partnership, offset by cash and cash equivalents and equity.
(US$ MILLIONS, except as noted)
2025
2024
Corporate borrowings
$
1,325
$
2,142
Non-recourse borrowings in subsidiaries of the partnership
42,424
36,720
Cash and cash equivalents
(3,546)
(3,239)
Net debt
40,203
35,623
Total equity
15,311
17,308
Total capital
$
55,514
$
52,931
Net debt-to-capital ratio
72 
%
67 
%
Schedule of Disclosure of liquidity management
The following tables detail the contractual maturities for the partnership’s financial liabilities as at December 31, 2025 and 2024. The tables reflect the undiscounted future cash flows of financial liabilities based on the earliest date on which the partnership can be required to repay. The tables include both interest and principal cash flows:
2025
Total contractual cash flows
(US$ MILLIONS)
< 1 Year
1-2 Years
2-5 Years
5+ Years
Non-derivative financial liabilities
Accounts payable and other (1)
$
5,825 
$
409 
$
432 
$
658 
$
7,324 
Interest-bearing liabilities
4,261 
7,065 
28,913 
19,595 
59,834 
Lease liabilities
241 
200 
265 
251 
957 
____________________________________
(1)Excludes decommissioning liabilities, other provisions, post-employment benefits, liability for remaining coverage, deferred revenue, liabilities associated with assets held for sale, work in progress liabilities and related party loans and notes payable of $5,680 million.
2024
Total contractual cash flows
(US$ MILLIONS)
< 1 Year
1-2 Years
2-5 Years
5+ Years
Non-derivative financial liabilities
Accounts payable and other (1)
$
5,977 
$
408 
$
501 
$
1,751 
$
8,637 
Interest-bearing liabilities
4,262 
6,287 
29,907 
12,632 
53,088 
Lease liabilities
223 
215 
332 
502 
1,272 
___________________________________
(1)Excludes decommissioning liabilities, other provisions, post-employment benefits, liability for remaining coverage, deferred revenue, liabilities associated with assets held for sale, work in progress liabilities and related party loans and notes payable of $7,835 million.
Schedule of Disclosure of interest rate risk
As at December 31, 2025 and 2024, a 50 basis point increase or decrease in interest rates would have the following impact on the partnership’s profit measures on a pre-tax basis, assuming all other variables were held constant:
Net income (loss)
Other comprehensive income (loss)
(US$ MILLIONS)
50 bps decrease
50 bps increase
50 bps decrease
50 bps increase
December 31, 2025
$
47 
$
(47)
$
(2)
$
2 
December 31, 2024
$
35 
$
(35)
$
(30)
$
30 
Schedule of Disclosure of foreign currency exposure
The following tables summarize the partnership’s currency exposure as at December 31, 2025 and 2024:
2025
(US$ MILLIONS)
USD
AUD
GBP
CAD
EUR
BRL
INR
Other
Total
Assets
Current assets
$
7,119 
$
969 
$
542 
$
1,411 
$
1,718 
$
1,828 
$
401 
$
1,055 
$
15,043 
Non-current assets
28,001 
7,271 
2,195 
5,079 
8,978 
6,292 
776 
2,126 
60,718 
$
35,120 
$
8,240 
$
2,737 
$
6,490 
$
10,696 
$
8,120 
$
1,177 
$
3,181 
$
75,761 
Liabilities
Current liabilities
$
3,216 
$
1,072 
$
575 
$
701 
$
1,386 
$
1,200 
$
382 
$
450 
$
8,982 
Non-current liabilities
30,440 
5,587 
714 
2,966 
6,007 
5,363 
252 
139 
51,468 
$
33,656 
$
6,659 
$
1,289 
$
3,667 
$
7,393 
$
6,563 
$
634 
$
589 
$
60,450 
Interest of others in operating subsidiaries
343 
768 
884 
1,366 
2,379 
1,102 
393 
1,885 
9,120 
Preferred securities
740 
 
 
 
 
 
 
 
740 
Unitholder equity
$
381 
$
813 
$
564 
$
1,457 
$
924 
$
455 
$
150 
$
707 
$
5,451 
2024
(US$ MILLIONS)
USD
AUD
GBP
CAD
EUR
BRL
INR
Other
Total
Assets
Current assets
$
7,505 
$
1,111 
$
637 
$
1,199 
$
1,620 
$
1,575 
$
740 
$
952 
$
15,339 
Non-current assets
27,132 
9,426 
2,197 
4,750 
8,019 
5,681 
902 
2,028 
60,135 
$
34,637 
$
10,537 
$
2,834 
$
5,949 
$
9,639 
$
7,256 
$
1,642 
$
2,980 
$
75,474 
Liabilities
Current liabilities
$
5,716 
$
1,839 
$
507 
$
715 
$
1,288 
$
909 
$
752 
$
440 
$
12,166 
Non-current liabilities
23,152 
7,634 
738 
4,061 
5,357 
4,583 
354 
121 
46,000 
$
28,868 
$
9,473 
$
1,245 
$
4,776 
$
6,645 
$
5,492 
$
1,106 
$
561 
$
58,166 
Interest of others in operating subsidiaries
3,834 
588 
1,136 
530 
2,030 
1,249 
342 
1,742 
11,451 
Preferred securities
740 
— 
— 
— 
— 
— 
— 
— 
740 
Unitholder equity
$
1,195 
$
476 
$
453 
$
643 
$
964 
$
515 
$
194 
$
677 
$
5,117 
Schedule of Disclosure of sensitivity analysis for foreign currency risk The following tables summarize the partnership’s exposures to foreign currencies and the sensitivity of net income and other comprehensive income, on a pre-tax basis, to a 10% change in the exchange rates relative to the U.S. dollar for the years ended December 31, 2025, 2024 and 2023:
 
December 31, 2025
Pre-tax net income
OCI attributable to Unitholders, before taxes
(US$ MILLIONS)
10% decrease
10% increase
10% decrease
10% increase
Australian dollar
$
(4)
$
4 
$
(41)
$
41 
Canadian dollar
(3)
3 
(86)
86 
Brazilian real
(40)
40 
(59)
59 
Euro
92 
(92)
(89)
89 
Other
(64)
64 
(136)
136 
 
December 31, 2024
Pre-tax net income
OCI attributable to Unitholders, before taxes
(US$ MILLIONS)
10% decrease
10% increase
10% decrease
10% increase
Australian dollar
$
14 
$
(14)
$
(33)
$
33 
Canadian dollar
(9)
(5)
Brazilian real
(6)
(37)
37 
Euro
72 
(72)
(89)
89 
Other
(187)
187 
(122)
122 
 
December 31, 2023
Pre-tax net income
OCI attributable to Unitholders, before taxes
(US$ MILLIONS)
10% decrease
10% increase
10% decrease
10% increase
Australian dollar
$
— 
$
— 
$
(84)
$
84 
Canadian dollar
(10)
10 
(115)
115 
Brazilian real
(1)
(23)
23 
Euro
19 
(19)
(109)
109 
Other
(59)
59 
(111)
111 
Schedule of Disclosure of reconciliation of gross carrying amounts
The following table shows changes in the gross carrying amount of the partnership’s significant loans receivable portfolio for the years ended December 31, 2025 and 2024:
(US$ MILLIONS)
Stage 1
Stage 2
Stage 3
Total
Gross carrying amount
Balance at January 1, 2024
$
6,233 
$
563 
$
153 
$
6,949 
New assets originated or purchased
2,441 
168 
19 
2,628 
Assets derecognized (excluding write-offs)
(2,137)
(216)
(94)
(2,447)
Transfers to stage 1
83 
(76)
(7)
— 
Transfers to stage 2
(577)
599 
(22)
— 
Transfers to stage 3
(57)
(91)
148 
— 
Amounts written-off (net of recovery)
(1)
(1)
(8)
(10)
Other
(266)
(38)
(13)
(317)
Foreign currency translation
(446)
(68)
(12)
(526)
Balance at December 31, 2024
$
5,273 
$
840 
$
164 
$
6,277 
New assets originated or purchased
2,158 
106 
9 
2,273 
Assets derecognized (excluding write-offs)
(2,217)
(339)
(89)
(2,645)
Transfers to stage 1
98 
(92)
(6)
 
Transfers to stage 2
(338)
360 
(22)
 
Transfers to stage 3
(39)
(91)
130 
 
Amounts written-off (net of recovery)
(3)
(7)
(31)
(41)
Other
(69)
(31)
(33)
(133)
Foreign currency translation
283 
54 
7 
344 
Balance at December 31, 2025
$
5,146 
$
800 
$
129 
$
6,075 
The ECL allowance of the partnership’s significant loans receivable portfolio as at December 31, 2025 was $10 million for Stage 1 assets (2024: $11 million), $7 million for Stage 2 assets (2024: $9 million) and $25 million for Stage 3 assets (2024: $27 million). The impact on ECL allowance for exposures transferred between stages during the year was not significant.